ArticleBMC veterinary research2026
Optimal dietary nano-VD₃ enhances growth performance and bone development in broilers through remodeling the gut microbiome and metabolites.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSkeletal maldevelopment is a significant challenge in broiler production, causing substantial economic losses. Vitamin D₃ (VD₃) plays a critical role in poultry skeletal health, but its optimal dietary inclusion level for medium-growth broilers remains to be determined due to bioavailability differences among forms. This study investigated the effects of dietary VD₃ levels (conventional vs. nano-formulated) on growth performance, bone development, and gut microbiota composition and metabolite profile in broilers. A total of 420 one-day-old male Luhua broilers were randomly assigned to four groups in an 84-day experiment: a control group fed a basal diet, and three treatment groups supplemented with 3,750 IU/kg conventional VD₃ (CVD), 2,500 IU/kg low-dose nano-VD
resultsBoth CVD and LNVD significantly enhanced average daily gain (ADG) and bone development by improving bone mineral content (BMC) and bone mineral density (BMD), mechanical properties (yield strength, stiffness, Elastic modulus), increasing calcium and ash content, and upregulating osteogenic gene expression (ALP, OC, OPG, BMP1) in the femur and tibia. Compared to CVD, LNVD led to significantly higher ADG from days 1-84 and greater bone indices at days 28, 56 and 84, including fresh bone weight (FBW), fat-free dry weight (FFDW), yield strength, elastic modulus, and calcium and ash content in the femur and tibia. In contrast, HNVD significantly decreased ADG and bone indices. Furthermore, cecal microbiome and metabolomics analysis showed that LNVD increased the relative abundance of beneficial bacteria (e.g., Ligilactobacillus, Muribaculaceae, NK4A214_group) and key metabolites (e.g., butyric acid, kynurenic acid, glutathione), while reducing harmful taxa (e.g., Desulfovibrio, Campylobacter_jejuni) and detrimental metabolites (e.g., leukotriene E3, 4-hydroxy-2-nonenal-Cys-Gly conjugate). These shifts significantly correlated with improved growth and bone traits.
conclusionsIn summary, 2,500 IU/kg nano-VD₃ is recommended as the optimal supplementation level for Luhua broilers under the conditions of this study, offering a strategy to enhance VD₃ nutrition and skeletal health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.